None
Quote | 3SBIO Inc (OTCMKTS:TRSBF)
Last: | $0.80 |
---|---|
Change Percent: | 0.0% |
Open: | $0.8 |
Close: | $0.80 |
High: | $0.8 |
Low: | $0.8 |
Volume: | 9,003 |
Last Trade Date Time: | 06/29/2022 04:37:39 am |
News | 3SBIO Inc (OTCMKTS:TRSBF)
2023-11-05 02:15:00 ET Summary Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for its next-gen PARP1 inhibitor to Germany’s Merck KGaA. BioLineRx, an Israeli biotech, out-licensed China rights to a stem cell mobilizer for multiple myeloma and stem cell disease...
BeiGene began trading on the Shanghai STAR Board as the last step in its $3.5 billion IPO. The company is now listed in the US, Hong Kong and Shanghai. Jinan Qilu Pharma entered a $300 million agreement to acquire greater China rights to an RNAi therapy for hepatitis B developed by Ar...
Message Board Posts | 3SBIO Inc (OTCMKTS:TRSBF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |